New Data Strengthens Teva’s Schizophrenia Portfolio, Including Phase 3 SOLARIS Trial Survey Results Demonstrating Patient and Healthcare Professional Satisfaction with TEV-'749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable 1-04-2025, 00:00

Monsha’at: 23 agreements worth over SAR 580 million signed on Day 3 of Biban 2024 8-11-2024, 16:50

Noor Riyadh 2023: The world’s largest annual festival of light and art returns to Saudi Arabia’s Capital, with over 120 artworks by more than 100 local and international artists 30-11-2023, 18:15